This opportunity is no longer accepting applications.
grant RFA-CA-25-013

Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)

This grant aims to support research in discovering and developing new natural products that can safely and effectively prevent or intercept cancer. It is divided into two phases: the first phase (UG3) focuses on selecting important clinical targets and developing tests to assess bioactivity and toxicity. The second phase (UH3) involves screening compound libraries, understanding their structur…

The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention. 1. Purpose of UG3: Select clinically relevant targets and develop an…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute

Dates

Opportunity Released: October 1, 2024
Open for Submission: October 1, 2024
Submission Deadline: June 13, 2025
Application Window Closes: June 13, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.